Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope

被引:38
作者
Gilmore, RD
Mbow, ML
机构
[1] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Publ Hlth Serv,US Dept Hlth & Human Serv, Ft Collins, CO 80522 USA
[2] Colorado State Univ, Dept Pathol, Ft Collins, CO 80523 USA
关键词
D O I
10.1128/IAI.67.10.5463-5469.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Active immunization with Escherichia coli-expressed recombinant outer surface protein C (OspC) of Borrelia burgdorferi has been demonstrated to confer protection against a tick-transmitted infection on laboratory animals. A previous study in this laboratory showed that OspC antibody raised against a denatured immunogen isolated from B. burgdorferi cells failed to provide protective immunity. Therefore, to determine whether the protective epitope of the recombinant antigen was sensitive to denaturation, recombinant OspC preparations were subjected to heat and chemical treatments prior to animal immunization. Following seroconversion to OspC, the animals were challenged with an infectious dose of B. burgdorferi B31 by tick bite. Whereas mice immunized with a soluble, nondenatured form continued to show protection rates close to 100%, mice that had been immunized with denatured antigen were not protected. furthermore, mice that were immunized,vith an insoluble (rather than a soluble), nondenatured form of the recombinant OspC showed a protection rate of only 40%. Protective epitope localization experiments showed that either the amino or the carboxy end of the recombinant protein was required to react with a protective OspC-specific monoclonal antibody. The data from these experiments demonstrate that a conformational organization of the protein is essential for the protective capability of the strain B31 OspC immunogen.
引用
收藏
页码:5463 / 5469
页数:7
相关论文
共 29 条
[21]   EAR PUNCH BIOPSY METHOD FOR DETECTION AND ISOLATION OF BORRELIA-BURGDORFERI FROM RODENTS [J].
SINSKY, RJ ;
PIESMAN, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (08) :1723-1727
[22]   ANTIBIOTIC-THERAPY IN LYME-DISEASE [J].
STEERE, AC ;
MALAWISTA, SE ;
NEWMAN, JH ;
SPIELER, PN ;
BARTENHAGEN, NH .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (01) :1-8
[23]   LYME-DISEASE [J].
STEERE, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (09) :586-596
[24]   Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant [J].
Steere, AC ;
Sikand, VK ;
Meurice, F ;
Parenti, DL ;
Fikrig, E ;
Schoen, RT ;
Nowakowski, J ;
Schmid, CH ;
Laukamp, S ;
Buscarino, C ;
Krause, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :209-215
[25]   POLYMORPHISM IN OSPC GENE OF BORRELIA-BURGDORFERI AND IMMUNOREACTIVITY OF OSPC PROTEIN - IMPLICATIONS FOR TAXONOMY AND FOR USE OF OSPC PROTEIN AS A DIAGNOSTIC ANTIGEN [J].
THEISEN, M ;
FREDERIKSEN, B ;
LEBECH, AM ;
VUUST, J ;
HANSEN, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2570-2576
[26]   ELECTROPHORETIC TRANSFER OF PROTEINS FROM POLYACRYLAMIDE GELS TO NITROCELLULOSE SHEETS - PROCEDURE AND SOME APPLICATIONS [J].
TOWBIN, H ;
STAEHELIN, T ;
GORDON, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (09) :4350-4354
[27]   IMMUNOLOGICAL AND MOLECULAR POLYMORPHISMS OF OSPC, AN IMMUNODOMINANT MAJOR OUTER SURFACE PROTEIN OF BORRELIA-BURGDORFERI [J].
WILSKE, B ;
PREACMURSIC, V ;
JAURIS, S ;
HOFMANN, A ;
PRADEL, I ;
SOUTSCHEK, E ;
SCHWAB, E ;
WILL, G ;
WANNER, G .
INFECTION AND IMMUNITY, 1993, 61 (05) :2182-2191
[28]   CHARACTERIZATION OF A DISULFIDE BRIDGE-STABILIZED ANTIGENIC DOMAIN OF TICK-BORNE ENCEPHALITIS-VIRUS STRUCTURAL GLYCOPROTEIN [J].
WINKLER, G ;
HEINZ, FX ;
KUNZ, C .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2239-2244
[29]   Therapeutic passive vaccination against chronic Lyme disease in mice [J].
Zhong, WM ;
Stehle, T ;
Museteanu, C ;
Siebers, A ;
Gern, L ;
Kramer, M ;
Wallich, R ;
Simon, MM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12533-12538